12th Clinical Biomarker & CDx Europe Summit

Date & Time 27-28 April 2022
Address The Tower Hotel,
St Katherine's Way
Location London, UK

In 2021 the life science industry witnessed rapid precision medicine progress led by increased understanding of disease heterogeneity and diagnostic innovation. 12th Clinical Biomarker & CDx Europe Summit ensures you’re in the room alongside the biomarker & diagnostic community to address regulatory changes, exchange novel ideas, gather lessons learned and develop new partnerships at a pivotal moment for precision medicine progress in Europe.

The event aims to:

  • Advance Innovative Biomarker Discovery and Development through improvements in non-invasive testing, optimising biomarker translation, the development of robust clinically validated assays and leveraging multi-omic analyses for effectively identifying patient populations with superior efficacy and clinical outcomes.
  • Define Market-Leading Drug-Dx Co-Development & Commercialisation Strategies by forging strong collaborations with industry partners, creating awareness for new biomarker implementation, synchronizing drug-dx regulatory approval and market introduction and confidently navigating the nuanced European reimbursement landscape.
  • Gain Clarity from European & Global Regulatory Expectations by gathering as an industry to address IVDR’s impacts on clinical, CDx and precision pipeline decision making, changing UK IVD regulation, developing biomarkers providing a clear path forward with regulatory agencies and US, EU & APAC market differences for launching biomarker-driven drug programs.


Make sure you catch Emanuela Oldoni, EATRIS Scientific Program Manager, who will be speaking on 28 April at 10:00 CEST. Her talk is titled: “EATRIS-Plus: The Development of a Multi-Omic Tool Box for Performing High-Quality Research in Personalised Medicine“.

The event is free to attend for all drug developers, academics and researchers. Find out more here.